Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer’s disease
暂无分享,去创建一个
[1] K. Blennow,et al. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. , 2019, JAMA neurology.
[2] N. Greig,et al. Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Traumatic Brain Injury. , 2019, Journal of neurotrauma.
[3] A. Gabelle,et al. HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links? , 2018, Front. Cell. Neurosci..
[4] K. Blennow,et al. Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy , 2018, Journal of NeuroVirology.
[5] E. Abner,et al. Deficient neurotrophic factors of CSPG4‐type neural cell exosomes in Alzheimer disease , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] R. Stern,et al. Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel , 2018, Brain injury.
[7] L. Lannfelt,et al. Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers , 2018, Acta Neuropathologica.
[8] A. Puccio,et al. Exosomes in Acquired Neurological Disorders: New Insights into Pathophysiology and Treatment , 2018, Molecular Neurobiology.
[9] P. Martinelli,et al. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias , 2018, Alzheimer's Research & Therapy.
[10] G. Jicha,et al. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] M. Mattson,et al. In a randomized trial in prostate cancer patients, dietary protein restriction modifies markers of leptin and insulin signaling in plasma extracellular vesicles , 2017, Aging cell.
[12] L. Pulliam,et al. Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV , 2017, AIDS.
[13] K. Blennow,et al. Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology‐based cohort , 2017, European journal of neurology.
[14] E. Peskind,et al. Biofluid biomarkers of traumatic brain injury , 2017, Brain injury.
[15] K. Blennow,et al. Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls , 2017, Expert review of molecular diagnostics.
[16] E. Goetzl,et al. Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes , 2017, Front. Neurosci..
[17] A. Granholm,et al. Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome , 2017, Alzheimer's & Dementia.
[18] Alzheimer's Disease Neuroimaging Initiative. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease , 2017 .
[19] Henrik Zetterberg,et al. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease , 2017, JAMA neurology.
[20] Lu Yang,et al. Emerging roles of extracellular vesicles in neurodegenerative disorders: focus on HIV-associated neurological complications , 2016, Cell Death and Disease.
[21] Roland Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[22] G. Jicha,et al. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] L. Pulliam,et al. Monocyte exosomes induce adhesion molecules and cytokines via activation of NF‐κB in endothelial cells , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] D. Galasko,et al. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile , 2016, Alzheimer's & dementia.
[25] J. Trojanowski,et al. Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging , 2016, Annals of clinical and translational neurology.
[26] C. Théry,et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes , 2016, Proceedings of the National Academy of Sciences.
[27] K. Blennow,et al. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study , 2015, EBioMedicine.
[28] Sagar H. Barage,et al. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease , 2015, Neuropeptides.
[29] R. Petersen,et al. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease , 2015, Neurology.
[30] R. Petersen,et al. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study , 2015, Alzheimer's & Dementia.
[31] R. Petersen,et al. Low neural exosomal levels of cellular survival factors in Alzheimer’s disease , 2015, Annals of clinical and translational neurology.
[32] R. Petersen,et al. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] C. Yiannoutsos,et al. Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection , 2014, PloS one.
[34] B. Vissel,et al. Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease , 2014, Acta neuropathologica communications.
[35] L. Pulliam,et al. Exosomes as mediators of neuroinflammation , 2014, Journal of Neuroinflammation.
[36] A. Hill,et al. Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases? , 2012, Front. Physio..
[37] E. Masliah,et al. Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients , 2009, Journal of Neuroimmune Pharmacology.
[38] E. Masliah,et al. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients , 2005, AIDS.
[39] Lynn Pulliam,et al. HIV-1 Tat inhibits neprilysin and elevates amyloid β , 2005 .
[40] L. Pulliam,et al. P3-371 HIV-1 TAT inhibits neprilysin and elevates amyloid beta , 2004, Neurobiology of Aging.
[41] N. Norgren,et al. Elevated neurofilament levels in neurological diseases , 2003, Brain Research.
[42] G. Broggi,et al. Efficacy of ‘8-drugs-in-one-day’ combination in treatment of recurrent GBM patients , 1992, Journal of Neuro-Oncology.
[43] A. Wallin,et al. Differential Impact of Neurofilament Light Subunit on Cognition and Functional Outcome in Memory Clinic Patients with and without Vascular Burden. , 2015, Journal of Alzheimer's disease : JAD.
[44] L. Hersh,et al. Tat peptides inhibit neprilysin , 2011, Journal of NeuroVirology.
[45] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .